Omnia SanaPlant Comparison
Astragalus vs Black Cumin
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Astragalus and Black Cumin: they share 7 indicated uses (arthritis / joint pain, cancer (anticancer research), cold & flu, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Astragalus | Black Cumin | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Black Cumin |
| Cancer (anticancer research) | 2/10 | 7/10 | Stronger for Black Cumin |
| Cold & flu | 2/10 | 5/10 | Stronger for Black Cumin |
| Immune support | 2/10 | 5/10 | Stronger for Black Cumin |
| Infection (general) | 2/10 | 5/10 | Stronger for Black Cumin |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Black Cumin |
| Skin irritation | 1/10 | 5/10 | Stronger for Black Cumin |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Major bioactive saponin with cardio-, neuro-, hepato- and renoprotective effects.
The principal bioactive constituent of the seed oil, responsible for much of its anti-inflammatory, antioxidant and antimicrobial activity.
The aromatic fraction of the seed, contributing antimicrobial and antioxidant activity.
The bulk lipid fraction of the seed (roughly a third of seed weight by weight), the carrier for the fat-soluble thymoquinone.
Minor isoquinoline-type alkaloids studied for antioxidant activity.
Triterpene saponin studied for anticancer and antiparasitic activity.
Pharmacological Actions
Astragalus membranaceus and its constituents (astragaloside IV, cycloastragenol, Astragalus polysaccharide) inhibit tumour growth, invasion and metastasis and enhance antitumour immunity across lung, colorectal and gastrointestinal cancers (preclinical, incl. in vivo).
Immune support / immunomodulation (activates macrophages, NK cells, T and B lymphocytes)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Astragalus membranaceus protects against gastrointestinal cancers; astragaloside IV inhibits lung cancer metastasis via macrophage repolarization, cycloastragenol boosts CD8+ T-cell antitumour immunity (with anti-PD-1 synergy), and Astragalus polysaccharide suppresses inflammation-induced colorectal cancer (preclinical).
Supports resistance to colds and respiratory infection (immune)
Adaptogenic tonic for fatigue and low vitality (traditional 'Qi' tonic)
Immune support / immunomodulation (activates macrophages, NK cells, T and B lymphocytes); Supports resistance to colds and respiratory infection (immune)
Supports resistance to colds and respiratory infection (immune)
inferred from anti-inflammatory action
Renoprotective (kidney support) - as an adjunct in chronic kidney disease, reduced proteinuria and raised haemoglobin and serum albumin across trials (Cochrane review; study quality low)
inferred from anti-inflammatory action
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from analgesic action
inferred from digestive action
inferred from antidiabetic action
inferred from anticancer action
inferred from immunomodulator action
inferred from analgesic action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Astragalus stimulates immune activity; on theoretical grounds it should be used cautiously in autoimmune disease and with immunosuppressant medicines (for example after organ transplant) - discuss with a clinician.
Generally well tolerated; high-quality long-term human safety and toxicity data remain limited.
Safety in pregnancy and breastfeeding has not been established; avoid medicinal doses.
Generally well-tolerated in clinical trials at doses up to 200 mg/day of oil for 90 days. Potential side effects may include mild gastrointestinal discomfort. Contraindicated during pregnancy due to potential uterine stimulant effects. May interact with immunosuppressants and antidiabetic medications. Allergic reactions possible in sensitive individuals. Consult healthcare provider before use, especially with concurrent medications.
Duke (2002) describes black cumin (Nigella sativa) as one of the most multi-active medicinal spices, with experimental evidence for bronchodilation, immunostimulation, hepatoprotection, and antihistaminic activity. The prophet Muhammad reportedly described it as 'a cure for all things except death.' Key bioactive compounds include thymoquinone and nigellone. Antihistaminic and bronchodilatory activity supports its traditional use in asthma and allergic conditions. Duke notes it is generally safe at culinary amounts but recommends caution with medicinal doses in pregnancy due to potential uterotonic effects (Duke, 2002).
External Ids
Botanical Description
Erect perennial herb with a long, fibrous, pale yellow taproot. The leaves are pinnately compound with numerous small, oval leaflets, giving a soft, ferny appearance. Small, pale yellow, pea-like flowers are borne in loose axillary clusters (racemes), followed by membranous, inflated seed pods that give the species its name.[5]
Annual herb (Ranunculaceae), 20-90 cm tall, with an erect, branched stem and finely divided, pinnately dissected, fern-like leaves. Delicate pale blue-white (occasionally pale purple) flowers, each with 5-10 petal-like sepals, are surrounded by a feathery bract collar. The fruit is an inflated, many-celled capsule that dries and splits to release numerous small, black, angular seeds - the medicinal part.[1]
Habitat
Native to the grasslands, sunny slopes and forest margins of northern and north-eastern China, Mongolia and parts of Korea; widely cultivated as a medicinal crop across East Asia.[5]
Native to the Mediterranean basin, southern Europe, western Asia and North Africa, and widely cultivated as a spice and medicinal crop across the Middle East, South Asia and North Africa; grows in cultivated fields and on disturbed ground.[1]
Harvesting
The root is dug from plants at least four years old, typically in spring or autumn, then cleaned and dried, often sliced into the characteristic pale, fibrous 'coin' slices used in traditional decoctions.[5]
Seed capsules are harvested once dried and brown (late summer), then threshed to release the small black seeds. Seed is stored whole and either used directly or cold-pressed for oil shortly before use to preserve the volatile thymoquinone-rich fraction.[1]
Traditional Uses
One of the most celebrated medicinal seeds in Middle Eastern and Islamic traditional medicine - known as 'Habbatul Barakah' (the blessed seed) - black seed has traditionally been used for digestive complaints, respiratory conditions (asthma, cough), pain, inflammation, skin conditions and as a general tonic. Modern research on its principal constituent thymoquinone supports broad anti-inflammatory, antioxidant, antimicrobial, antidiabetic and immunomodulatory activity.[1, 2, 9]
Preparations
Dosage
The WHO monograph on Radix Astragali gives doses of 3-9 g per day. Traditional Chinese medicine references often cite a considerably higher 9-30 g of dried root per day; WHO's figure is the conservative regulatory-tier one and is stated here in preference. Educational reference only, not a prescription.
Clinical studies commonly use extracts providing the equivalent of several grams of dried root daily, in divided doses. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Xu, B., Huang, J.P., Peng, G., Cao, W., Liu, Z. et al (2024) 'Total biosynthesis of the medicinal triterpenoid saponin astragalosides', Nature Plants, 10(11), pp. 1826-1837. doi:10.1038/s41477-024-01827-4 Preclinical
https://doi.org/10.1038/s41477-024-01827-4 - Auyeung, K.K., Han, Q.B. and Ko, J.K (2016) 'Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers', The American Journal of Chinese Medicine, 44(1), pp. 1-22. doi:10.1142/S0192415X16500014 Traditional / reference
https://doi.org/10.1142/S0192415X16500014 - Zhang, Y., Ji, W., Qin, H., Chen, Z., Zhou, Y. et al (2024) 'Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17/Treg cell homeostasis in a microbiota-dependent manner', Carbohydrate Polymers, 349, pp. 122829. doi:10.1016/j.carbpol.2024.122829 Preclinical
https://doi.org/10.1016/j.carbpol.2024.122829 - Fu, J., Wang, Z., Huang, L., Zheng, S., Wang, D., Chen, S., Zhang, H. and Yang, S (2014) 'Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi)', Phytotherapy Research, 28(9), pp. 1275-1283. doi:10.1002/ptr.5188 Meta-analysis / review
https://doi.org/10.1002/ptr.5188 - Zhang, J., Wu, C., Gao, L., Du, G. and Qin, X (2019) 'Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects', Advances in Pharmacology. doi:10.1016/bs.apha.2019.08.002 Traditional / reference
https://doi.org/10.1016/bs.apha.2019.08.002 - Dong, M., Li, J., Yang, D., Li, M. and Wei, J (2023) 'Biosynthesis and pharmacological activities of flavonoids, triterpene saponins and polysaccharides derived from Astragalus membranaceus', Molecules, 28(13), pp. 5018. doi:10.3390/molecules28135018 Meta-analysis / review
https://doi.org/10.3390/molecules28135018 - Chen, G., Jiang, N., Zheng, J., Hu, H., Yang, H., Lin, A., Hu, B. and Liu, H (2023) 'Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus', International Journal of Biological Macromolecules, 241, pp. 124386. doi:10.1016/j.ijbiomac.2023.124386 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.124386 - Zheng, Q., Zhuang, Z., Wang, Z., Deng, L., Jin, W., Huang, Z., Zheng, G. and Wang, Y (2020) 'Clinical and preclinical systematic review of Astragalus membranaceus for viral myocarditis', Oxidative Medicine and Cellular Longevity, 2020, pp. 1560353. doi:10.1155/2020/1560353 Meta-analysis / review
https://doi.org/10.1155/2020/1560353 - Dai, Y., Wang, Y., Kang, Q., Wu, Y., Liu, Y., Su, Y., Wang, X., Xiu, M. and He, J (2024) 'The protective effect and bioactive compounds of Astragalus membranaceus against neurodegenerative disorders via alleviating oxidative stress in Drosophila', FASEB Journal, 38(13), pp. e23727. doi:10.1096/fj.202400390R Preclinical
https://doi.org/10.1096/fj.202400390R - Xu, L., Xu, X., Hou, X., Wang, F., Gao, S. and Zhang, H (2019) 'Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review', Metabolic Brain Disease, 35(1), pp. 83-93. doi:10.1007/s11011-019-00483-4 Meta-analysis / review
https://doi.org/10.1007/s11011-019-00483-4 - Li, C.X., Liu, Y., Zhang, Y.Z., Li, J.C. and Lai, J (2022) 'Astragalus polysaccharide: a review of its immunomodulatory effect', Archives of Pharmacal Research. doi:10.1007/s12272-022-01393-3 Preclinical
https://doi.org/10.1007/s12272-022-01393-3 - Jin, M., Zhao, K., Huang, Q. and Shang, P (2014) 'Structural features and biological activities of the polysaccharides from Astragalus membranaceus', International Journal of Biological Macromolecules, 64, pp. 257-266. doi:10.1016/j.ijbiomac.2013.12.002 Preclinical
https://doi.org/10.1016/j.ijbiomac.2013.12.002 - Liu, Y. and Lv, W (2019) 'Research progress in Astragalus membranaceus and its active components on immune responses in liver fibrosis', Chinese Journal of Integrative Medicine, 26(10), pp. 794-800. doi:10.1007/s11655-019-3039-1 Meta-analysis / review
https://doi.org/10.1007/s11655-019-3039-1 - World Health Organization (1999) 'Radix Astragali'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Xu, F. and Cui, W.-Q. and Wei, Y. and Cui, J. and Qiu, J. and Hu, L.-L. and Gong, W.-Y. and Dong, J.-C. and Liu, B.-J (2018) 'Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling', Journal of Experimental & Clinical Cancer Research, 37(1), pp. 207. doi:10.1186/s13046-018-0878-0 Preclinical
https://doi.org/10.1186/s13046-018-0878-0 - Deng, G. and Zhou, L. and Wang, B. and Sun, X. and Zhang, Q. and Chen, H. and Wan, N. and Ye, H. and Wu, X. and Sun, D. and Sun, Y. and Cheng, H (2022) 'Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation', Journal for ImmunoTherapy of Cancer, 10(10), pp. e004874. doi:10.1136/jitc-2022-004874 Preclinical
https://doi.org/10.1136/jitc-2022-004874 - Li, Q. and Zhang, C. and Xu, G. and Shang, X. and Nan, X. and Li, Y. and Liu, J. and Hong, Y. and Wang, Q. and Peng, G (2024) 'Astragalus polysaccharide ameliorates CD8 T cell dysfunction through STAT3/Gal-3/LAG3 pathway in inflammation-induced colorectal cancer', Biomedicine & Pharmacotherapy, 171, pp. 116172. doi:10.1016/j.biopha.2024.116172 Preclinical
https://doi.org/10.1016/j.biopha.2024.116172 - Zhang, H.W., Lin, Z.X., Xu, C., Leung, C. and Chan, L.S (2014) 'Astragalus (a traditional Chinese medicine) for treating chronic kidney disease', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008369.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD008369.pub2
- Hannan, M.A., Rahman, M.A., Sohag, A.A.M., Uddin, M.J., Dash, R., Sikder, M.H., Rahman, M.S., Timalsina, B., Munni, Y.A. and Sarker, P.P (2021) 'Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety', Nutrients, 13(6), pp. 1784. doi:10.3390/nu13061784 Meta-analysis / review
https://doi.org/10.3390/nu13061784 - Ahmad, A., Husain, A., Mujeeb, M., Khan, S.A., Najmi, A.K., Siddique, N.A., Damanhouri, Z.A. and Anwar, F (2013) 'A review on therapeutic potential of Nigella sativa: A miracle herb', Asian Pacific Journal of Tropical Biomedicine, 3(5), pp. 337-352. doi:10.1016/S2221-1691(13)60075-1 Meta-analysis / review
https://doi.org/10.1016/S2221-1691(13)60075-1 - Chatterjee, G., Saha, A.K., Khurshid, S. and Saha, A (2025) 'A Comprehensive Review of the Antioxidant, Antimicrobial, and Therapeutic Efficacies of Black Cumin (Nigella sativa L.) Seed Oil and Its Thymoquinone', Journal of Medicinal Food, 28(4), pp. 325-339. doi:10.1089/jmf.2024.k.0149 Meta-analysis / review
https://doi.org/10.1089/jmf.2024.k.0149 - Majdalawieh, A.F. and Fayyad, M.W (2015) 'Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review', International Immunopharmacology, 28(1), pp. 295-304. doi:10.1016/j.intimp.2015.06.023 Meta-analysis / review
https://doi.org/10.1016/j.intimp.2015.06.023 - Shaukat, A., Zaidi, A., Anwar, H. and Kizilbash, N (2023) 'Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review', Frontiers in Nutrition, 10, pp. 1126272. doi:10.3389/fnut.2023.1126272 Meta-analysis / review
https://doi.org/10.3389/fnut.2023.1126272 - Beheshti, F., Khazaei, M. and Hosseini, M (2016) 'Neuropharmacological effects of Nigella sativa', Avicenna Journal of Phytomedicine, 6(1), pp. 104-116. Meta-analysis / review
https://scholar.google.com/scholar?q=Neuropharmacological%20effects%20of%20Nigella%20sativa - Shafiq, H., Ahmad, A., Masud, T. and Kaleem, M (2014) 'Cardio-protective and anti-cancer therapeutic potential of Nigella sativa', Iranian Journal of Basic Medical Sciences, 17(12), pp. 967-979. Meta-analysis / review
https://scholar.google.com/scholar?q=Cardio-protective%20and%20anti-cancer%20therapeutic%20potential%20of%20Nigella%20sativa - Bordoni, L., Fedeli, D., Nasuti, C., Maggi, F., Papa, F., Wabitsch, M., De Caterina, R. and Gabbianelli, R (2019) 'Antioxidant and Anti-Inflammatory Properties of Nigella sativa Oil in Human Pre-Adipocytes', Antioxidants, 8(2), pp. 51. doi:10.3390/antiox8020051 Preclinical
https://doi.org/10.3390/antiox8020051 - Gholamnezhad, Z., Havakhah, S. and Boskabady, M.H (2016) 'Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review', Journal of Ethnopharmacology, 190, pp. 372-386. doi:10.1016/j.jep.2016.06.061 Meta-analysis / review
https://doi.org/10.1016/j.jep.2016.06.061 - Ali, B.H. and Blunden, G (2003) 'Pharmacological and toxicological properties of Nigella sativa', Phytotherapy Research, 17(4), pp. 299-305. doi:10.1002/ptr.1309 Meta-analysis / review
https://doi.org/10.1002/ptr.1309 - Al-Attass, S.A., Zahran, F.M. and Turkistany, S.A (2016) 'Nigella sativa and its active constituent thymoquinone in oral health', Saudi Medical Journal, 37(3), pp. 235-244. doi:10.15537/smj.2016.3.13006 Meta-analysis / review
https://doi.org/10.15537/smj.2016.3.13006 - Ahmad A, Husain A, Mujeeb M, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013;3 (2013) ';3(5):337-352', 3(5). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3642442/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC3642442/ - Darakhshan S, Bidmeshki Pour A, Hosseinzadeh Colagar A, Sisakhtnezhad S. Thymoquinone and its therapeutic potentials. Pharmacol Res. 2015;95-96:138-158. https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ (2015) ';95-96:138-158'. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ - Forouzanfar F, Bazzaz BSF, Hosseinzadeh H. A review of ethnobotany, phytochemistry, antimicrobial pharmacology and toxicology of Nigella sativa L. Biomed Pharmacother. 2021;142:112040. https://www.sciencedirect.com/science/article/pii/S0753332221009665 (2021) ';142:112040'. Available at: https://www.sciencedirect.com/science/article/pii/S0753332221009665 Traditional / reference
https://www.sciencedirect.com/science/article/pii/S0753332221009665 - Gholamnezhad Z, Keyhanmanesh R, Boskabady MH. Anti-inflammatory, antioxidant, and immunomodulatory aspects of Nigella sativa for its preventive and bronchodilatory effects on obstructive respiratory diseases. Biomed Pharmacother. 2021;136:111240. https://www.sciencedirect.com/science/article/pii/S0753332221002778 (2021) ';136:111240'. Available at: https://www.sciencedirect.com/science/article/pii/S0753332221002778 Traditional / reference
https://www.sciencedirect.com/science/article/pii/S0753332221002778 - Hannan MA, Rahman MA, Sohag AAM, et al. Black cumin (2021) ';13(6):1784', 13(6). doi:10.3389/fphar.2021.625386/full Randomized trial
https://doi.org/10.3389/fphar.2021.625386/full - Kooti W, Hasanzadeh-Noohi Z, Sharafi-Ahvazi N, et al. Phytochemistry, pharmacology, and therapeutic uses of black seed (2016) ';22(3):231-237', 22(3). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8225153/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC8225153/ - Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (2017) ';20(3):179-193', 20(3). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5633670/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC5633670/ - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Saadati, S., Naseri, K., Asbaghi, O., Abhari, K., Zhang, P., Li, H.B. and Gan, R.Y (2022) 'Nigella sativa supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials', Frontiers in Nutrition, 9, pp. 977756. doi:10.3389/fnut.2022.977756 Meta-analysis / review
https://doi.org/10.3389/fnut.2022.977756 - Willcox, M.L., Elugbaju, C., Al-Anbaki, M., Lown, M. and Graz, B (2021) 'Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials', Frontiers in Pharmacology, 12, pp. 777561. doi:10.3389/fphar.2021.777561 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.777561 - Daryabeygi-Khotbehsara, R., Golzarand, M., Ghaffari, M.P. and Djafarian, K (2017) 'Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: a systematic review and meta-analysis', Complementary Therapies in Medicine, 35, pp. 6-13. doi:10.1016/j.ctim.2017.08.016 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2017.08.016 - Sahebkar, A., Soranna, D., Liu, X., Thomopoulos, C., Simental-Mendia, L.E., Derosa, G., Maffioli, P. and Parati, G (2016) 'A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure', Journal of Hypertension, 34(11), pp. 2127-2135. doi:10.1097/HJH.0000000000001049 Meta-analysis / review
https://doi.org/10.1097/HJH.0000000000001049 - Kavyani, Z., Musazadeh, V., Safaei, E., Mohammadi Asmaroud, M., Khashakichafi, F., Ahrabi, S.S. and Dehghan, P (2023) 'Antihypertensive effects of Nigella sativa supplementation: an updated systematic review and meta-analysis of randomized controlled trials', Phytotherapy Research, 37(8), pp. 3224-3238. doi:10.1002/ptr.7891 Meta-analysis / review
https://doi.org/10.1002/ptr.7891
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.